维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="ROCHLITZ C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Targeting tumorassociated endothelial cells: anti- VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth 显示文摘	Wicki A Rochlitz C Orleth A	2012	Clin Cancer Res2012，18，2：	1
2	Breast cancer-treatment guidelines and new treat-ment options in 2012,a medical oncology prospective显示文摘	Vetter M Rochlitz C		0，，10：	1
3	Targeted therapies in breast can- cer显示文摘	WICKI A ROCHLITZ C	2012	Swiss Med Wkly2012，142，13：	1
4	Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUCI-positive advanced ctmcer显示文摘	ROCHLITZ C FIGLIN R SQUIBAN P	2003	J Gene Med2003，5，8：	1
5	Targeting tumor-associated endothelial cells:anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth显示文摘	Wicki A Rochlitz C Orleth A	2012	Clin Cancer Res2012，18，2：	1
6	Targeting tumor-associated en- dothelial cells: Anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth显示文摘	Wicki A Rochlitz C Orleth A	2012	Clin Cancer Res2012，18，2：	1
7	Phase I immunotherapy with a modified vaecinia virus (NVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive ad- vanced cancer显示文摘	Rochlitz C Figlin R Squiban P	2003	J Gene Ned2003，5，：	1
8	Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUCl-posi- rive advanced cancer显示文摘	Rochlitz C Figlin R Squiban P	2003	J Gene Med2003，5，8：	1
9	Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumors 显示文摘	Rochlitz C Jantscheff P Bongartz G	1999	Cancer Gene Ther1999，6，3：	1
10	An open-label,noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer显示文摘	Salzberg M Rochlitz C Morant R	2007	Onkologie2007，30，7：	1
11	A phase Ⅰ study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non- small cell lung cancer显示文摘	Sehuler M Rochlitz C Horowitz JA	1998	Hum Gene Ther1998，9，14：	1
12	Phase I immu- notherapy with a modified vaccinia virus (MVA) ex- pressing human MUC1 as antigen-specific immuno- therapy in patients with MUCl-positive advanced cancer显示文摘	Rochlitz C Figlin R Squiban P	2003	J Gene Med2003，5，8：	1
13	Breast cancer-treatment guidelines a- nd new treatment options in 2012, a medical oncology pro- spective显示文摘	Vetter M Rochlitz C	2012	Ther Umsch2012，69，10：	1
14	Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia(AML):results from a multicenter trial of the Swiss Group for Clinical Cancer Research(SAKK)显示文摘	Rochlitz C Lohri A Bacchi M	1999	Leukemia1999，13，9：	1
15	Cancer gene and immunotherapy:recent developments显示文摘	JANTSCHEFF P HERRMANN R ROCHLITZ C	1999	Med Oncol1999，16，：	1
16	Phase I immunotherapy with a modified vaccinia virus(MVA)expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer显示文摘	Rochlitz C Figlin R Squiban P	2003	J Gene Med2003，5，8：	1
17	Cancer gene and immunotherapy: recent developments 显示文摘	Jantscheff P Herrmann R Rochlitz C	1999	Med Oneol1999，16，2：	1
18	Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigenspecific immunotherapy in patients with MUC1-positive advanced cancer显示文摘	ROCHLITZ C FIGLIN R SQUIBAN P	2003	J Gene Med2003，5，8：	1
19	Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUCl-positive advanced cancer显示文摘	Rochlitz C Figlin R Squiban P	2003	J Gene Med2003，5，：	1
20	Multidrug resistance gene expression in human renal cell cancer is associated with the histologic subtype显示文摘	Rochlitz C Lobeck H Peter S	1992	Cancer1992，69，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示